“Odyssey Therapeutics has recently run a complex, cell-based HTS at Pivot Park Screening Centre. I was particularly impressed by their “can-do” spirit in the rapid miniaturization and execution of the project, thereby cutting reagent costs and timelines. The culture of a company like PPSC, which includes a refreshing directness and transparency, is a good fit with the no-nonsense attitude of a demanding biotech partner. On the technical front, PPSC boasts robust automation resulting in excellent screening results and plate statistics. Together with the assay optimization and adaptation, the ultimate robotic execution of the screen ran nearly flawlessly. Having personally managed a large, well-equipped HTS facility for many years, the collaboration with PPSC was like going back home!”
Jeff Hermes
Executive VP and Head of Enabling Sciences
Odyssey Therapeutics
Boston, MA
